Biological E's Corbevax gets DCGI nod as a heterologous Covid booster dose

The Hyderabad-based company claimed that the booster dose of Corbevax increased the neutralising antibody titers in the Covishield and Covaxin groups significantly when compared to placebo

Biological E’s Corbevax becomes the first vaccine to get the Drug Controller General of India’s (DCGI) nod to be used as a heterologous booster for adults who have either received two shots of Covaxin or Covishield.

India’s vaccine policy think tank National Technical Advisory Group on Immunisation (NTAGI) is also studying data on vaccine dose mixing, but has not yet come out with a decision. So far, India was using a homologous booster shot for all precaution doses. However, Biological E claimed that now a Corbevax shot can be booked through the Co-WIN portal by anyone who wished to take a